Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOVO-TRIOLAM TAB 0.125MG DIN 00872423

Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Molecule: TRIAZOLAM .125 MG

Health Canada record

Active ingredient(s)TRIAZOLAM .125 MG
Dosage formTablet
RouteOral
ScheduleTARGETED SUBSTANCES (CDSA IV)
ClassHuman
ATCN05CD05 TRIAZOLAM
Original market date31-Dec-1990
Current status date10-Aug-2005
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TRIAZOLAM .125 MG

DINProductCompanyFormStrengthStatus
00614351ALTI-TRIAZOLAM TAB 0.125MGALTIMED PHARMA INC.TabletTRIAZOLAM .125 MGCancelled Post Market
02232553PENTA-TRIAZOLAM TABLETSPENTAPHARM LTD.TabletTRIAZOLAM .125 MGCancelled (Unreturned Annual)
00860816TRIAZOLAM TAB 0.125MGPRO DOC LIMITEETabletTRIAZOLAM .125 MGCancelled Post Market
Request a quote for NOVO-TRIOLAM TAB 0.125MG

How to read a Canadian DIN record